Case Control Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jun 21, 2021; 27(23): 3357-3371
Published online Jun 21, 2021. doi: 10.3748/wjg.v27.i23.3357
Table 3 Associations between abdominal fat phenotypes and pancreatic enzymes
Fat phenotypeHealthy
T2DM
NODAP

β
S.E.
P value
β
S.E.
P value
β
S.E.
P value
Intra-pancreatic fat (%)
Pancreatic amylase-0.8322.2200.7120.5731.7090.741-2.2010.8990.023
Pancreatic lipase 0.2580.4210.546-0.6310.3970.8761.3431.4620.367
Chymotrypsin-0.1370.1790.452-0.5790.6100.3430.1640.2700.550
Liver fat (%)
Pancreatic amylase0.6850.4440.140-0.0220.1570.890-0.4930.3310.151
Pancreatic lipase -0.1360.0890.141-0.1340.3510.709-0.0980.2800.730
Chymotrypsin0.0020.0400.967-0.0710.0690.3140.0590.0510.259
Skeletal muscle fat (%)
Pancreatic amylase-0.5700.5950.351-0.2410.4740.619-0.1850.1250.151
Pancreatic lipase 0.1950.0930.047-1.3450.9120.161-0.0710.4460.875
Chymotrypsin-0.0230.0440.609-0.1290.1050.238-0.0140.0860.868
Visceral fat (cm3)
Pancreatic amylase0.0020.0050.6640.0000.0020.841-0.0040.0020.028
Pancreatic lipase -0.5880.8390.490-3.2470.4620.4930.5330.2500.833
Chymotrypsin-0.3140.3620.3940.2870.5660.6190.2400.4580.606
Subcutaneous fat (cm3)
Pancreatic amylase0.0030.0020.2240.0000.0020.821-0.0020.0010.232
Pancreatic lipase -0.5730.4820.246-2.0323.4440.564-0.0361.9310.985
Chymotrypsin-0.0300.2150.890-0.5270.5340.338-0.0910.3500.797